Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.164ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.164ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.164ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.164NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.275ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.275ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.275ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.275NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.58ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.58NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.81ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.81ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.81NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.419ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.419ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.419ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.419NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.151ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.151ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.151ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.151NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.53 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.53 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.53 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.599ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.599ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.599ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.599NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.128ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.128ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used